Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Fluticasone
A STEROID with GLUCOCORTICOID RECEPTOR activity that is used to manage the symptoms of ASTHMA; ALLERGIC RHINITIS, and ATOPIC DERMATITIS.
Year introduced: 2016 (1990)
Fluticasone-Salmeterol Drug Combination
A drug combination of fluticasone and salmeterol that is used as an inhaler formulation to manage the symptoms of ASTHMA and CHRONIC OBSTRUCTIVE PULMONARY DISEASE.
Year introduced: 2016 (2001)
fluticasone propionate-17-carboxylic acid [Supplementary Concept]
metabolite of fluticasone propionate; structure in first source
Date introduced: May 9, 2010
fluticasone-formoterol [Supplementary Concept]
a mixture of fluticasone propionate and formoterol fumarate
Date introduced: February 22, 2014
MP29-02 [Supplementary Concept]
formulation of azelastine and fluticasone propionate
Date introduced: July 26, 2012
fluticasone furoate [Supplementary Concept]
a glucocorticoid; structure in first source
Date introduced: October 1, 2007
APT-1011 [Supplementary Concept]
a fluticasone propionate orally disintegrating tablet formulation
Date introduced: September 18, 2020
fluticasone furoate-vilanterol trifenatate [Supplementary Concept]
for Asthma therapy
Date introduced: November 2, 2016